Bionano Genomics, Inc. Earnings Per Share (Diluted)
Bionano Genomics, Inc. (BNGO) reported Earnings Per Share (Diluted) of -$0.64 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-10
- Bionano Genomics, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.64.
- Bionano Genomics, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.76.
- Bionano Genomics, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.77.
- Bionano Genomics, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$1.59.
- Bionano Genomics, Inc. earnings per share, diluted for fiscal 2025 was -$4.85.
- Bionano Genomics, Inc. earnings per share, diluted for fiscal 2024 was -$88.13.
- Bionano Genomics, Inc. earnings per share, diluted for fiscal 2023 was -$408.60.
- Bionano Genomics, Inc. earnings per share, diluted for fiscal 2022 was -$4.58.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.64 10-Q · filed 2026-08-10 | -$1.40 10-Q · filed 2026-08-10 | -$2.16 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$3.37 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2026-03-31 | -$0.76 10-Q · filed 2026-05-13 | -$1.53 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$2.79 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$4.21 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2025-12-31 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$2.10 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$3.66 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$4.85 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | -$1.59 10-Q · filed 2025-11-13 | -$3.50 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$4.82 10-Q · filed 2025-11-13 | -$11.77 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2025-06-30 | -$1.99 10-Q · filed 2026-08-10 | -$3.24 10-Q · filed 2026-08-10 | -$11.60 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$32.28 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2025-03-31 | -$1.15 10-Q · filed 2026-05-13 | -$10.70 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$35.08 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$48.54 derived: net income ÷ weighted average shares · filed 2026-08-10 | ||||
| 2024-12-31 | -$12.23 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$41.84 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$57.53 derived: net income ÷ weighted average shares · filed 2026-03-23 | -$88.13 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | -$30.92 10-Q · filed 2025-11-13 | -$0.52 10-Q · filed 2024-11-14 | -$47.30 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$80.18 10-Q · filed 2025-11-13 | -$1.34 10-Q · filed 2024-11-14 | $5.97 derived: net income ÷ weighted average shares · filed 2025-11-13 | ||
| 2024-06-30 | -$14.41 10-Q · filed 2025-08-14 | -$0.24 10-Q · filed 2024-08-07 | -$47.50 10-Q · filed 2025-08-14 | -$0.79 10-Q · filed 2024-08-07 | $2.97 derived: net income ÷ weighted average shares · filed 2025-11-13 | $14.21 derived: net income ÷ weighted average shares · filed 2025-11-13 | ||
| 2024-03-31 | -$35.75 10-Q · filed 2025-05-14 | -$0.60 10-Q · filed 2024-05-08 | $1.61 derived: net income ÷ weighted average shares · filed 2025-11-13 | $9.62 derived: net income ÷ weighted average shares · filed 2025-11-13 | $33.49 derived: net income ÷ weighted average shares · filed 2025-11-13 | |||
| 2023-12-31 | $0.46 derived: net income ÷ weighted average shares · filed 2025-03-31 | $5.26 derived: net income ÷ weighted average shares · filed 2025-03-31 | $20.96 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$408.60 10-K · filed 2025-03-31 | -$6.81 10-K · filed 2024-03-05 | |||
| 2023-09-30 | -$3.22 10-Q · filed 2024-11-14 | -$4.56 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$5.85 10-Q · filed 2024-11-14 | -$7.19 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-06-30 | -$1.24 10-Q · filed 2024-08-07 | -$2.46 10-Q · filed 2024-08-07 | -$3.77 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$4.87 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-03-31 | -$1.23 10-Q · filed 2024-05-08 | -$0.12 10-Q · filed 2023-05-09 | -$2.53 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$3.63 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$4.76 derived: net income ÷ weighted average shares · filed 2024-11-14 | |||
| 2022-12-31 | -$1.30 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$2.40 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$3.53 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$4.58 10-K · filed 2024-03-05 | -$0.46 10-K · filed 2023-03-09 | |||
| 2022-09-30 | -$1.10 10-Q · filed 2023-11-08 | -$0.11 10-Q · filed 2022-11-03 | -$2.22 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$3.28 10-Q · filed 2023-11-08 | -$0.33 10-Q · filed 2022-11-03 | -$0.75 derived: net income ÷ weighted average shares · filed 2023-11-08 | ||
| 2022-06-30 | -$1.13 10-Q · filed 2023-08-09 | -$0.11 10-Q · filed 2022-08-04 | -$2.18 10-Q · filed 2023-08-09 | -$0.22 10-Q · filed 2022-08-04 | -$0.43 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.48 derived: net income ÷ weighted average shares · filed 2023-11-08 | ||
| 2022-03-31 | -$0.11 10-Q · filed 2023-05-09 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.26 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.33 derived: net income ÷ weighted average shares · filed 2023-11-08 | ||||
| 2021-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$0.26 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | -$0.07 10-Q · filed 2022-11-03 | -$0.14 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$0.18 10-Q · filed 2022-11-03 | |||||
| 2021-06-30 | -$0.07 10-Q · filed 2022-08-04 | -$0.11 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | -$0.04 10-Q · filed 2022-05-05 | |||||||
| 2020-09-30 | -$0.08 10-Q · filed 2021-11-04 | -$0.17 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$0.34 10-Q · filed 2021-11-04 | |||||
| 2020-06-30 | -$0.09 10-Q · filed 2021-08-04 | -$0.29 10-Q · filed 2021-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |